Billionaire Stan Druckenmiller's Small-Cap Stock Picks: Top 5 Stocks
In this piece, we will take a look at billionaire Stanley Druckenmiller's top five small-cap stock picks.
Recursion Pharmaceuticals Inc. (RXRX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | MIC Capital Partners Mubadala Investment | 8,451,758 | $63,134,635 | 12.84% | |
| 2. | ARK Investment Management Catherine D. Wood | 4,738,517 | $35,396,723 | +33% | 0.23% |
| 3. | Laurion Capital Management Benjamin A. Smith | 3,178,179 | $23,740,997 | -35% | 0.13% |
| 4. | Platinum Asset Management Kerr Neilson | 2,711,148 | $20,252,276 | -3% | 0.7% |
| 5. | Cercano Management Chris Orndorff | 978,051 | $7,306,041 | 0.25% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $7.82 | 66,822 | Large Shareholder | 12,985,927 | 2023-03-02 | Filing | |
| $7.94 | 48,867 | Large Shareholder | 12,919,105 | 2023-03-01 | Filing | |
| $7.97 | 815 | Large Shareholder | 12,870,238 | 2023-02-28 | Filing | |
| $7.69 | 52,500 | Large Shareholder | 12,869,423 | 2023-02-27 | Filing | |
| $7.64 | 109,118 | Large Shareholder | 12,816,923 | 2023-02-24 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $8.66 | 18,000 | Officer | 140,351 | 2023-09-15 | Filing | |
| $8.69 | 25,000 | Officer | 888,186 | 2023-09-13 | Filing | |
| $8.43 | 25,000 | Officer | 875,686 | 2023-09-12 | Filing | |
| $8.84 | 1,000 | Officer, Director | 0 | 2023-09-06 | Filing | |
| $8.83 | 20,000 | Officer, Director | 0 | 2023-09-06 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 25,097,630 | $187,479,296 | 0.16% | |
| 2. | 11,619,427 | $86,797,118 | 0% | |
| 3. | 11,259,832 | $84,110,946 | 0% | |
| 4. | 10,405,668 | $77,730,340 | 100% | |
| 5. | 5,941,120 | $44,380,166 | 32.85% |
News See All
Top 10 Growth Stocks in Biotech
The biotech industry encompasses a wide range of fields, including genetic engineering, biomanufacturing, bioinformatics, and synthetic biology.
5 AI Healthcare Stocks To Buy
AbCellera Biologics Inc. (NASDAQ:ABCL) is a Canadian company that is operating in the domain of human antibodies.
Harvard University Stock Portfolio: Top 10 Picks
Harvard Management Company was established in 1974 and manages Harvard University's endowment and financial assets.
Is Recursion Pharmaceuticals (RXRX) a Worthy Investment?
Lux Capital, an investment management firm, published its second quarter 2022 investor letter – a copy of which can be downloaded here.
Harvard University's Latest Portfolio: 5 Best Biotech Stock Picks
In this article, we will look at Harvard University's latest stock portfolio and list its 5 best biotech stock picks.
Cathie Wood's Top 10 Buys in July
In the beginning of July, Cathie Wood of ARK Investment Management admitted that while her predictions about inflation were wrong, the US seems to be heading towards a deflationary environment.
9 Healthcare Stocks to Invest In Today According to Stanley Druckenmiller
In this piece, we will take a look at the nine healthcare stocks to invest in today according to Stanley Druckenmiller.
5 Biotech Stocks to Buy Today According to Kerr Neilson's Platinum Asset Management
In this piece, we will take a look at the five biotechnology stocks to buy today according to Kerr Neilson's Platinum Asset Management.
Analysts Are Downgrading These 10 Pharmaceutical Stocks
In this article, we present the 10 pharmaceutical stocks that are being downgraded by analysts.
Billionaire Hedge Funds
